GlaxoSmithKline Pharmaceuticals Limited (GLAXO.BO)

INR 2306.25

(-1.23%)

Total Assets Summary of GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited's latest annual total assets in 2023 was 35.73 Billion INR , up 7.43% from previous year.
GlaxoSmithKline Pharmaceuticals Limited's latest quarterly total assets in 2024 Q2 was 37.45 Billion INR , down 0.0% from previous quarter.
GlaxoSmithKline Pharmaceuticals Limited reported annual total assets of 33.26 Billion INR in 2022, down -28.2% from previous year.
GlaxoSmithKline Pharmaceuticals Limited reported annual total assets of 46.33 Billion INR in 2021, up 48.76% from previous year.
GlaxoSmithKline Pharmaceuticals Limited reported quarterly total assets of 37.45 Billion INR for 2024 Q2, down 0.0% from previous quarter.
GlaxoSmithKline Pharmaceuticals Limited reported quarterly total assets of 35.73 Billion INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of GlaxoSmithKline Pharmaceuticals Limited (2023 - 2004)

Historical Annual Total Assets of GlaxoSmithKline Pharmaceuticals Limited (2023 - 2004)

Year	Total Assets	Total Assets Growth
2023	35.73 Billion INR	7.43%
2022	33.26 Billion INR	-28.2%
2021	46.33 Billion INR	48.76%
2020	31.14 Billion INR	-0.67%
2019	31.35 Billion INR	-19.83%
2018	39.11 Billion INR	-0.92%
2017	39.47 Billion INR	31.41%
2016	30.03 Billion INR	-1.67%
2015	30.54 Billion INR	-5.26%
2014	32.24 Billion INR	3.03%
2013	31.29 Billion INR	1.33%
2012	30.88 Billion INR	1.94%
2011	30.29 Billion INR	7.8%
2010	28.1 Billion INR	12.52%
2009	24.97 Billion INR	7.64%
2008	23.2 Billion INR	13.97%
2007	20.36 Billion INR	13.81%
2006	17.89 Billion INR	18.02%
2005	15.15 Billion INR	7.21%
2004	14.13 Billion INR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	- INR	-100.0%
2024 Q2	37.45 Billion INR	0.0%
2023 Q4	35.73 Billion INR	0.0%
2023 Q1	- INR	-100.0%
2023 Q2	32.7 Billion INR	0.0%
2023 FY	35.73 Billion INR	7.43%
2023 Q3	- INR	-100.0%
2022 Q4	33.26 Billion INR	0.0%
2022 FY	33.26 Billion INR	-28.2%
2022 Q1	- INR	-100.0%
2022 Q2	30.15 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2021 Q1	- INR	-100.0%
2021 FY	46.33 Billion INR	48.76%
2021 Q2	30.53 Billion INR	0.0%
2021 Q4	46.33 Billion INR	0.0%
2021 Q3	- INR	-100.0%
2020 Q3	- INR	-100.0%
2020 FY	31.14 Billion INR	-0.67%
2020 Q4	31.14 Billion INR	0.0%
2020 Q2	27.38 Billion INR	0.0%
2020 Q1	- INR	-100.0%
2019 Q4	31.35 Billion INR	0.0%
2019 FY	31.35 Billion INR	-19.83%
2019 Q1	- INR	-100.0%
2019 Q2	35.19 Billion INR	0.0%
2019 Q3	- INR	-100.0%
2018 Q4	39.11 Billion INR	0.0%
2018 Q1	- INR	0.0%
2018 FY	39.11 Billion INR	-0.92%
2017 FY	39.47 Billion INR	31.41%
2016 FY	30.03 Billion INR	-1.67%
2015 FY	30.54 Billion INR	-5.26%
2014 FY	32.24 Billion INR	3.03%
2013 FY	31.29 Billion INR	1.33%
2012 FY	30.88 Billion INR	1.94%
2011 FY	30.29 Billion INR	7.8%
2010 FY	28.1 Billion INR	12.52%
2009 FY	24.97 Billion INR	7.64%
2008 FY	23.2 Billion INR	13.97%
2007 FY	20.36 Billion INR	13.81%
2006 FY	17.89 Billion INR	18.02%
2005 FY	15.15 Billion INR	7.21%
2004 FY	14.13 Billion INR	0.0%

Peer Total Assets Comparison of GlaxoSmithKline Pharmaceuticals Limited

Name	Total Assets	Total Assets Difference
Abbott India Limited	51.93 Billion INR	31.188%
Cipla Limited	327.17 Billion INR	89.077%
Gland Pharma Limited	106.61 Billion INR	66.479%
Kopran Limited	7.43 Billion INR	-380.83%
Marksans Pharma Limited	26.8 Billion INR	-33.302%
NGL Fine-Chem Limited	3.55 Billion INR	-905.174%
Pfizer Limited	42.28 Billion INR	15.49%
Sanofi India Limited	17.14 Billion INR	-108.406%
SMS Pharmaceuticals Limited	10.34 Billion INR	-245.593%